Obinna N. Obianom, PhD

Principal Scientist II
Johnson and Johnson Innvoative Medicine

Poster(s):

• (S-077) Population Pharmacokinetic & Exposure-Response Analysis After Subcutaneous Administration of Guselkumab in Pediatric Participants with Moderate to Severe Plaque Psoriasis
  Sunday, October 19, 2025

  7:00 AM - 5:00 PM MDT